Systematic review of mammary analog secretory carcinoma of salivary glands at 7 years after description.

Systematic review of mammary analog secretory carcinoma of salivary glands at 7 years after description.

Head Neck. 2017 Apr 03;:

Authors: Khalele BA

Abstract
BACKGROUND: Mammary analog secretory carcinoma of the salivary glands (MASCSG ) is a newly introduced malignant tumor of the salivary glands. For decades, it has been confused with acinic cell carcinoma (ACC) of the salivary glands.
METHODS: All reported cases of MASCSG were surveyed from 2010 until January 2017. The collected data was compiled and computationally processed to describe the clinical parameters of MASCSG . Its epidemiology was also mapped. Moreover, inaccurate data was highlighted.
RESULTS: Clinically implicating, this article tackles simply the several clinical findings of MASCSG so that our contemporary nosology, at 7 years after description, can be updated. The cytogenetic, histologic, and immunohistochemical details are also defined.
CONCLUSION: The available data about MASCSG is sufficient enough to diagnose it with no need to investigate the ETV6-NTRK3 translocation. Although high-grade malignancy and distant metastases were rarely reported, a rapt attention should be paid both to the nature of this tumor and to the indicated close follow-up of such cases, especially when necrosis, increased mitotic activity, and other classic caveats are conspicuous. © 2017 Wiley Periodicals, Inc. Head Neck, 2017.

PMID: 28370824 [PubMed - as supplied by publisher]

http://ift.tt/2oxnktj